|
Re: Finance
|
7
|
Resverlogix Corp.
|
May 26, 2020 04:59PM
|
|
Re: Canaccord (#33) dumping stock
|
5
|
Resverlogix Corp.
|
May 26, 2020 01:39PM
|
|
Canaccord (#33) dumping stock
|
7
|
Resverlogix Corp.
|
May 26, 2020 12:33PM
|
|
Re: Nature Article on the role of Endothelial Cells in COVID 19
|
8
|
Resverlogix Corp.
|
May 23, 2020 07:58PM
|
|
STAT News article on stopping COVID 19
|
7
|
Resverlogix Corp.
|
May 21, 2020 09:19AM
|
|
Nature Article on the role of Endothelial Cells in COVID 19
|
9
|
Resverlogix Corp.
|
May 21, 2020 08:41AM
|
|
Re: The therapeutic potential of BRD4 in cardiovascular disease
|
6
|
Resverlogix Corp.
|
May 20, 2020 08:50AM
|
|
Re: The therapeutic potential of BRD4 in cardiovascular disease
|
8
|
Resverlogix Corp.
|
May 20, 2020 08:33AM
|
|
Tocilizumab (IL - 6) not dead yet
|
4
|
Resverlogix Corp.
|
May 17, 2020 10:01AM
|
|
Starting Dialysis Sooner Leads to Poorer Outcomes
|
5
|
Resverlogix Corp.
|
May 14, 2020 04:25PM
|
|
Re: Apabetalone - BET protein inhibition in cardiovascular disease and Type 2 diabetes
|
1
|
Resverlogix Corp.
|
May 08, 2020 03:30PM
|
|
Re: Report of exempt distribution
|
1
|
Resverlogix Corp.
|
May 07, 2020 04:21PM
|
|
Re: Report of exempt distribution
|
5
|
Resverlogix Corp.
|
May 07, 2020 02:26PM
|
|
Re: Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies
|
5
|
Resverlogix Corp.
|
May 06, 2020 09:17PM
|
|
Lots of new options and deferred share units issued on Friday
|
5
|
Resverlogix Corp.
|
May 06, 2020 09:18AM
|
|
Farxiga (SGLT2i) approved for heart failure
|
3
|
Resverlogix Corp.
|
May 06, 2020 08:53AM
|
|
Insider - Option Expiry
|
2
|
Resverlogix Corp.
|
May 01, 2020 11:15PM
|
|
Re: Some more reading material
|
3
|
Resverlogix Corp.
|
May 01, 2020 08:12PM
|
|
Re: Todays trading
|
6
|
Resverlogix Corp.
|
Apr 29, 2020 02:43PM
|
|
Re: Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies
|
12
|
Resverlogix Corp.
|
Apr 27, 2020 02:39PM
|
